KR960013376A - 철과 디프룩토오스를 함유하는 빈혈치료제 - Google Patents

철과 디프룩토오스를 함유하는 빈혈치료제 Download PDF

Info

Publication number
KR960013376A
KR960013376A KR1019950036039A KR19950036039A KR960013376A KR 960013376 A KR960013376 A KR 960013376A KR 1019950036039 A KR1019950036039 A KR 1019950036039A KR 19950036039 A KR19950036039 A KR 19950036039A KR 960013376 A KR960013376 A KR 960013376A
Authority
KR
South Korea
Prior art keywords
iron
difructose
anemia treatment
anemia
containing iron
Prior art date
Application number
KR1019950036039A
Other languages
English (en)
Other versions
KR0159838B1 (ko
Inventor
백부현
이영우
이용복
Original Assignee
백부현
대원제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 백부현, 대원제약 주식회사 filed Critical 백부현
Publication of KR960013376A publication Critical patent/KR960013376A/ko
Application granted granted Critical
Publication of KR0159838B1 publication Critical patent/KR0159838B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

본 발명에 따르면, 철과 디프록토오스를 함유하는 철결핍성 빈혈치료제가 제공된다. 상기 빈혈치료제에 포함되는 철과 디프록토오스는 복합체를 형성할 수도 있으며, 그 몰비는 1:0.5 - 1:1,000 사이이다.
또한, 본 발명의 빈혈치료제에는 시아노코발아민, 피리독신 염산염, 엽산 등의 조혈인자가 추가로 포함될 수 있다.

Description

철과 디프록토오스를 함유하는 빈혈치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 철과 디프룩토오스를 함유하는 철결핍성 빈혈 치료제.
  2. 제1항에 있어서, 철과 디프룩토오스가 복합체(complex)를 형성하고 있는 철결핍성 빈혈 치료제.
  3. 제1항 또는 제2항에 있어서, 철과 디프룩토오스의 몰비가 1:0.5내지 1:1,000인 빈혈 치료제.
  4. 제3항에 있어서, 철과 디프룩토오스의 몰비가 1:0.5내지 1:10인 빈혈치료제.
  5. 제1항 또는 제2항에 있어서, 조혈 인자를 추가로 함유하는 것을 특징으로 하는 빈혈치료제.
  6. 제5항에 있어서, 조혈 인자가 시아노코발아민, 피리독신 염산염 및 엽산에서 선택된 1종 이상의 것임을 특징으로 하는 빈혈치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950036039A 1994-10-19 1995-10-18 철과 디프룩토오스를 함유하는 빈혈치료제 KR0159838B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19940026692 1994-10-19
KR94-26692 1994-10-19

Publications (2)

Publication Number Publication Date
KR960013376A true KR960013376A (ko) 1996-05-22
KR0159838B1 KR0159838B1 (ko) 1998-12-01

Family

ID=19395385

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950036039A KR0159838B1 (ko) 1994-10-19 1995-10-18 철과 디프룩토오스를 함유하는 빈혈치료제

Country Status (6)

Country Link
US (1) US5700832A (ko)
JP (1) JPH10507751A (ko)
KR (1) KR0159838B1 (ko)
AU (1) AU3674595A (ko)
GB (1) GB2308547B (ko)
WO (1) WO1996012484A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100384470B1 (ko) * 2000-12-29 2003-05-22 한국몰렉스 주식회사 커넥터 어셈블리

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772891B2 (en) 1998-12-11 2004-05-13 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
KR20020003344A (ko) * 2001-12-17 2002-01-12 유형선 철분 보급제 경구 투여 제제 조성물
US7754701B2 (en) 2002-04-26 2010-07-13 Fancl Corporation Difructose anhydride-containing composition and use thereof
US6960571B2 (en) * 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
JP5345751B2 (ja) * 2005-10-03 2013-11-20 日本甜菜製糖株式会社 家畜動物用貧血予防剤又は改善剤
MX2008013675A (es) 2006-04-26 2009-03-06 Supernus Pharmaceuticals Inc Preparaciones de liberacion controlada de oxcarbacepina que tienen perfil de liberacion sigmoidal.
JP5688628B1 (ja) * 2014-08-05 2015-03-25 聖一 村上 食品の風味・品質を向上させる方法と食品の風味・品質向上剤
RU2611636C1 (ru) * 2016-02-25 2017-02-28 Федеральное государственное бюджетное образовательное учреждение высшего образования Новосибирский государственный аграрный университет Гематоген
RU2671633C1 (ru) * 2017-11-30 2018-11-06 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Высокоэффективный гематоген

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT199793B (de) * 1956-08-04 1958-09-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung eines neuen Eiseninjektionspräparates für medizinische Zwecke
AT199794B (de) * 1957-08-01 1958-09-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung eines neuen Eiseninjektionspräparates für medizinische Zwecke
US3275514A (en) * 1960-04-12 1966-09-27 Paul D Saltman Process for introduction of metals into the mammalian system
US3086009A (en) * 1960-07-19 1963-04-16 Diamond Lab Inc Process for preparing a water soluble hydrolyzed starch-ferric iron complex
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
FR2601369B1 (fr) * 1986-07-11 1989-10-20 Beghin Say Sa Procede de preparation de dianhydrides du fructofuranose et leur utilisation comme additifs alimentaires.
DE3844065A1 (de) * 1988-12-28 1990-07-05 Orgaplan Gmbh Glycosidische eisen-ii- und eisen-iii-komplexzubereitungen und ihre verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100384470B1 (ko) * 2000-12-29 2003-05-22 한국몰렉스 주식회사 커넥터 어셈블리

Also Published As

Publication number Publication date
WO1996012484A1 (en) 1996-05-02
GB2308547A (en) 1997-07-02
KR0159838B1 (ko) 1998-12-01
JPH10507751A (ja) 1998-07-28
US5700832A (en) 1997-12-23
GB2308547B (en) 1998-08-12
GB9707820D0 (en) 1997-06-04
AU3674595A (en) 1996-05-15

Similar Documents

Publication Publication Date Title
ZA878952B (en) Metal complex-containing pharmaceutical agents
ATE218859T1 (de) Liganden des neuropeptids y
DE69331774T2 (de) 7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
GR3031897T3 (en) Antifungal nail solution
FR2387031A1 (fr) Composition pour shampooing a base d'un agent tensio-actif anionique et d'un ether cellulosique cationique
DE69428334T2 (de) Wässrige Lösungen enthaltend Inklusionskomplexe aus Benzothiophenderivaten und Cyclodextrinen
KR960013376A (ko) 철과 디프룩토오스를 함유하는 빈혈치료제
FR2624707B1 (fr) Trousse pour renfermer des instruments d'ecriture, etc...
IT8720200A0 (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine.
IT1298338B1 (it) Composizioni farmaceutiche per l'ulcera
CA2152771A1 (en) 7-o-ethers of taxane derivatives
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
DK0977582T3 (da) Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
TR200001745T2 (tr) Keton peroksit türevleri, bunların hazırlanması ve kullanılması
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
NO962243D0 (no) Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler
DE69609614D1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
DE69006508D1 (de) Azeotropähnliche zusammensetzungen von 1,3-dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.
DK0457127T3 (da) Spermicidt belægningsmiddel
ITRM910780A0 (it) Miscele di complessi di ferro, loro preparazione e loro impiego come coloranti. (caso 150-5458)
ATE165089T1 (de) Thiocarbamoylverbindungen als mikrobizide
KR920002113A (ko) 두발화장품 조성물
DE69012049T2 (de) In Immunoassays verwendbare stabilisierte Peroxidase-Zusammensetzung.
KR860002219A (ko) 투약 효과가 높도록 완제된 살서제

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090824

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee